Safety and efficacy of treatment with once-daily ledipasvir/sofosbuvir (90/400 MG) for 12 weeks in genotype 1 HCV-infected patients with severe renal impairment

The requested reference [d7fac657387abba5a39700c739136277d33904f3] no longer exists in our database. It has been replaced by the current reference: [5095d2b9a9f7141a2d10b644142ce70dca0e5290]

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: f72772da32c6d25f83b941ec74c95792e3971732
First added on: Feb 08, 2025